Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eli Lilly and Company
Orano Med LLC
Technische Universität Dresden
Amgen
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Providence Health & Services
National Cancer Institute (NCI)
Melanoma and Skin Cancer Trials Limited
National Cancer Center Hospital East
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
ITM Solucin GmbH
Washington University School of Medicine
Melanoma and Skin Cancer Trials Limited
Hoffmann-La Roche
Legend Biotech USA Inc
University Health Network, Toronto
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Novartis
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Columbia University
Columbia University
Eisai Inc.
Massachusetts Eye and Ear Infirmary
Olivia Newton-John Cancer Research Institute
Eastern Cooperative Oncology Group
Assistance Publique - Hôpitaux de Paris
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Hoffmann-La Roche
Corcept Therapeutics
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Advanced Accelerator Applications
University of Michigan Rogel Cancer Center
Alliance for Clinical Trials in Oncology